MeghanESheaMD

PubMed

• An evaluation of the utility of computed tomography in high-risk endometrial cancer surveillance.
  Elysia Larson, Taliya Lantsman, Corinne Jansen, Katharine Esselen, Meghan Shea> ;Cancer Treatment and Research Communications. 2024 Apr 4
• Non-surgical management of advanced ovarian cancer with maintenance PARP inhibitors.
  Jia, L., Lantsman, T., Shea, M.> ;Gynecologic Oncology Reports. 2024 Apr 1
• A Real-World Study of Patient Characteristics and Clinical Outcomes inMutated Lung Cancer Treated with First-Line Osimertinib: Expanding the FLAURA Trial Results into ...
  Emmeline Academia, Susumu S Kobayashi, Hollis Viray, Andrew J Piper-Vallillo, Page Widick, Meghan Shea, Deepa Rangachari, Paul A VanderLaan, Daniel B Costa> ;Cancers. 2024 Mar 7
• 1 citations
  Updated COVID-19 clearance time among patients with cancer in the Delta and Omicron waves.
  Zachary M Avigan, Rodrigo Paredes, Leora S Boussi, Barbara D Lam, Meghan E Shea, Matthew J Weinstock, Mary Linton B Peters> ;Cancer Medicine. 2023 Aug 1
• 1 citations
  Targeting thiol isomerase activity with zafirlukast to treat ovarian cancer from the bench to clinic.
  Justine A Gelzinis, Melanie K Szahaj, Roelof H Bekendam, Sienna E Wurl, Megan M Pantos, Christina A Verbetsky, Alexandre Dufresne, Meghan Shea, Kaitlind C Howard, Oleg...> ;FASEB Journal. 2023 May 1
• 16 citations
  A Phase II, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor-Positive Recurrent Endometrial Cancer.
  Kolin, D., Kolin, D., Panagiotis A Konstantinopoulos, Elizabeth K Lee, Niya Xiong, Carolyn Krasner, Susana Campos, David L Kolin, Joyce F Liu, Neil Horowitz, Alexi A W...> ;Journal of Clinical Oncology. 2023 Jan 20
• 12 citations
  Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer.
  Panagiotis A Konstantinopoulos, Allison A Gockley, Niya Xiong, Carolyn Krasner, Neil Horowitz, Susana Campos, Alexi A Wright, Joyce F Liu, Meghan Shea, Oladapo Yeku, C...> ;JAMA Oncology. 2022 Sep 1
• 2 citations
  Monitoring Endocrine Complications of Immunotherapy: A Screening Tool.
  Priyanka Majety, Anna Groysman, Virginia Seery, Meghan Shea, Runhua Hou> ;Cureus. 2022 Jul 1
• 1 citations
  Management of recurrent cervical cancer with peritoneal carcinomatosis with HIPEC.
  Taliya Lantsman, Marcos Lepe, Leslie Garrett, Martin Goodman, Meghan Shea> ;Gynecologic Oncology Reports. 2022 Feb 1
• 3 citations
  Implementing Electronic Patient-Reported Outcomes for Patients With New Oral Chemotherapy Prescriptions at an Academic Site and a Community Site.
  Jim Doolin, Jonathan L Berry, Natalia Forbath, N. Tocci, Tenzin Dechen, Stephanie Li, Rebekah A Hartwell, Jennifer K Espiritu, Daniel A Roberts, Jessica A. Zerillo, Me...> ;JCO Clinical Cancer Informatics. 2021 Jun 7
• 12 citations
  Association of extended dosing intervals or delays in pembrolizumab-based regimens with survival outcomes in advanced non-small cell lung cancer
  Kartik Sehgal, Anushi Bulumulle, Heather Brody, Ritu R. Gill, Shravanti Macherla, Aleksandra Qilleri, Danielle C. McDonald, Cynthia R. Cherry, Meghan Shea, Mark S. Hub...> ;Clinical Lung Cancer. 2021 May 1
• 36 citations
  Evaluating meaningful levels of financial toxicity in gynecologic cancers.
  Katharine M. Esselen, Annika Gompers, Michele R. Hacker, Sara Bouberhan, Meghan Shea, Sarah S. Summerlin, Lindsay Rucker, Warner K. Huh, Maria Pisu, Margaret I. Liang> ;International Journal of Gynecological Cancer. 2021 Apr 15
• 62 citations
  Association of Performance Status With Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy.
  Kartik Sehgal, Ritu R. Gill, Page Widick, Poorva Bindal, Danielle C. McDonald, Meghan Shea, Deepa Rangachari, Daniel B. Costa> ;JAMA Network Open. 2021 Feb 1
• 35 citations
  Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss
  Douglas I. Lin, Amanda Hemmerich, Claire Edgerly, Daniel Duncan, Eric Allan Severson, Richard S.P. Huang, Shakti H. Ramkissoon, Yamicia D. Connor, Meghan Shea, Jonatha...> ;Gynecologic Oncology. 2020 Mar 7
• 20 citations
  Germline mutations of SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type and in SMARCA4-deficient undifferentiated uterine sarcoma: Clinical features of ...
  Yamicia D. Connor, Diana Miao, Douglas I. Lin, Cynthia Hayne, Brooke E. Howitt, John L. Dalrymple, Kimberly R. DeLeonardis, Michele R. Hacker, Katharine M. Esselen, Me...> ;Gynecologic Oncology. 2020 Jan 15
• Reply to R.J. Buckanovich et al.
  Sara Bouberhan, Meghan Shea, Stephen A. Cannistra> ;Journal of Clinical Oncology. 2019 Aug 26
• 5 citations
  Advanced Epithelial Ovarian Cancer: Do More Options Mean Greater Benefits?
  Sara Bouberhan, Meghan Shea, Stephen A. Cannistra> ;Journal of Clinical Oncology. 2019 Apr 19
• 1 citations
  Maintenance PARP inhibitor therapy: is maintaining quality of life enough?
  Sara Bouberhan, Meghan Shea, Stephen A. Cannistra> ;The Lancet. Oncology. 2018 Oct 1
• 67 citations
  Safety and Efficacy of PD-1 Inhibitors Among HIV-Positive Patients With Non–Small Cell Lung Cancer
  Lorena Ostios-Garcia, Jennifer Faig, Giulia Costanza Leonardi, Anika E. Adeni, S. Subegdjo, Christine A. Lydon, Deepa Rangachari, Mark S. Huberman, Kartik Sehgal, Megh...> ;Journal of Thoracic Oncology. 2018 Jul 1
• 49 citations
  PD-L1 testing using the clone 22C3 pharmDx kit for selection of patients with non-small cell lung cancer to receive immune checkpoint inhibitor therapy: are cytology c...
  Vanda F. Torous, Deepa Rangachari, Benjamin P. Gallant, Meghan Shea, Daniel B. Costa, Paul A. VanderLaan> ;Journal of the American Society of Cytopathology. 2018 May 1
• 2 citations
  Polymyositis as a presentation of advanced carcinoma of Mullerian origin: A case report and discussion.
  Catherine Dieffenbach, Sara Bouberhan, Elizabeth M. Raynor, Meghan Shea, Fong Liu> ;Gynecologic Oncology Reports. 2018 May 1
• 9 citations
  Radiologic and autopsy findings in a case of fatal immune checkpoint inhibitor-associated pneumonitis.
  Meghan Shea, Deepa Rangachari, Robert W. Hallowell, Norris I. Hollie, Daniel B. Costa, Paul A. VanderLaan> ;Cancer Treatment and Research Communications. 2018 Jan 1
• 12 citations
  Cases of ALK-Rearranged Lung Cancer with 5-Year Progression-Free Survival with Crizotinib as Initial Precision Therapy.
  Deepa Rangachari, Xiuning Le, Meghan Shea, Mark S. Huberman, Paul A. VanderLaan, Susumu Kobayashi, Daniel B. Costa> ;Journal of Thoracic Oncology. 2017 Nov 1
• 106 citations
  Correlation between Classic Driver Oncogene Mutations in EGFR, ALK, or ROS1 and 22C3–PD-L1 ≥50% Expression in Lung Adenocarcinoma
  Deepa Rangachari, Paul A. VanderLaan, Meghan Shea, Xiuning Le, Mark S. Huberman, Susumu Kobayashi, Daniel B. Costa> ;Journal of Thoracic Oncology. 2017 May 1
• 15 citations
  Lazarus-Type Response to Crizotinib in a Patient with Poor Performance Status and Advanced MET Exon 14 Skipping Mutation–Positive Lung Adenocarcinoma
  Meghan Shea, Mark S. Huberman, Daniel B. Costa> ;Journal of Thoracic Oncology. 2016 Jul 1
• Join now to see all

Lectures

• VPI-2690B, a Novel Alphavbeta3 Integrin Antibody, Reduces Hyperglycemia-induced Changes in Renal Function in a Rat Model of Diabetic Nephropathy 
  Chapel Hill, NC - 6/14/2014